This is a solid paper on intermittent fasting that will be of interest to readers. The data presented are certainly valuable as a resource. The findings of both shared and tissue-specific signatures, ...

Chiesi Group & Arbor Biotechnologies enter global strategic partnership to develop novel rare disease gene editing programmes: Parma, Italy Tuesday, October 7, 2025, 14:00 Hrs [IS ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...

Chiesi Group partners with Arbor Biotechnologies to advance gene editing therapies for rare diseases, focusing on primary hyperoxaluria type 1.

Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...

This important work fills a gap in the characterization of motor architecture and chemical coupling of the male reproductive system, crucial to understanding male reproduction and fertility. The ...